Q4 2021 Holdings
Filed 2022-02-15 | 73 holdings | $62.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $94 | 3,666 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $209 | 4,500 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $225 | 10,000 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $271 | 107,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $348 | 10,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $511 | 60,000 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $617 | 40,200 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $741 | 15,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $797 | 25,500 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $833 | 10,700 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $851 | 18,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $905 | 67,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.1K | 61,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.1K | 94,600 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.1K | 58,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $1.2K | 26,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $1.3K | 36,100 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $1.4K | 16,200 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $1.4K | 63,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.5K | 32,500 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.6K | 25,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $1.6K | 215,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.6K | 28,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $2.0K | 21,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.1K | 139,331 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $2.1K | 19,500 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $2.2K | 135,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $2.2K | 153,000 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $2.4K | 68,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.4K | 38,958 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.6K | 109,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $2.8K | 94,800 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $2.8K | 24,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.9K | 61,741 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.1K | 45,000 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $3.2K | 120,535 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.2K | 155,500 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $3.3K | 121,100 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $4.7K | 289,389 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.1K | 383,233 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $5.6K | 44,200 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.6K | 476,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.9K | 113,456 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $7.5K | 74,500 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.6K | 12,100 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $8.2K | 108,200 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $8.7K | 297,500 | 0.0% |
| Exelixis Inc(EXC) | COM | 30161N101 | $10.0K | 546,534 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $10.1K | 236,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G4617B105 | $10.8K | 99,873 | 0.0% |